<DOC>
	<DOCNO>NCT02621736</DOCNO>
	<brief_summary>Monosymptomatic nocturnal enuresis ( MEN ) common problem child , affect 7-10 % 7 year old . MEN often lead psychosocial problem burden stigmatism . The available medical treatment option vasopressin analogum Desmopressin® . However , accord literature , one third patient show good treatment response , define 90 % reduce bed wet . Furthermore , treatment Desmopressin® may lead psychosocial problem , high cost potentially dangerous side effect like water intoxication hypertension . Copeptin , mirror arginine vasopressin ( AVP ) , show significantly low patient MEN compare control low patient severe bed wetting compare patient slight bed wetting .</brief_summary>
	<brief_title>Copeptin Prediction Treatment Response Children With Monosymptomatic Nocturnal Enuresis ( MEN ) .</brief_title>
	<detailed_description />
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Nocturnal Enuresis</mesh_term>
	<criteria>Children age 5 16 year Diagnosis monosymptomatic nocturnal enuresis Completion uroflowmetry bladder sonography possible Completion home recording chart bed wet episode possible Willingness use Desmopressin® treatment Children daytime enuresis Children low urinary tract symptom infection Children structural abnormality urinary tract Children chronic illness , esp . renal failure , hypertension , congenital heart disease , diabetes mellitus diabetes insipidus .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>child</keyword>
	<keyword>desmopressin</keyword>
	<keyword>copeptin</keyword>
</DOC>